The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study
Open accessAbstract
PURPOSE: The aim of the RUBY study was to evaluate novel candidate biomarkers to enable prediction of persistence of renal dysfunction as well as further understand potential mechanisms of kidney tissue damage and repair in acute kidney injury (AKI). METHODS: The RUBY study was a multi-center international prospective observational study to identify biomarkers of the persistence of stage 3 AKI as defined by the KDIGO criteria. Patients in the intensive care unit (ICU) with moderate or severe AKI (KDIGO stage 2 or 3) were enrolled. Patients were to be enrolled within 36 h of meeting KDIGO stage 2 criteria. The primary study endpoint was the development of persistent severe AKI (KDIGO stage 3) lasting for 72 h or more (NCT01868724). RESULTS: 364 patients were enrolled of whom 331 (91%) were available for the primary analysis. One hundred ten (33%) of the analysis cohort met the primary endpoint of persistent stage 3 AKI. Of the biomarkers tested in this study, urinary C-C motif chemokine ligand 14 (CCL14) was the most predictive of persistent stage 3 AKI with an area under the receiver operating characteristic curve (AUC) (95% CI) of 0.83 (0.78-0.87). This AUC was significantly greater than values for other biomarkers associated with AKI including urinary KIM-1, plasma cystatin C, and urinary NGAL, none of which achieved an AUC > 0.75. CONCLUSION: Elevated urinary CCL14 predicts persistent AKI in a large heterogeneous cohort of critically ill patients with severe AKI. The discovery of CCL14 as a predictor of persistent AKI and thus, renal non-recovery, is novel and could help identify new therapeutic approaches to AKI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KDIGO Clinical Practice Guidelines for Acute Kidney Injury
Khwaja, A. (2012) · Nephron Clinical Practice · doi:10.1159/000339789 · Cited by 8,014
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.1 · Cited by 4,326
Self-citationAcute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
Chawla, L. S., Eggers, P. W., Star, R. A., & Kimmel, P. L. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1214243 · Cited by 1,977
Self-citation16., O. B. O. T. A. D. Q. I. W., Chawla, L. S., Bellomo, R., Bihorac, A., Goldstein, S. L., Siew, E. D., Bagshaw, S. M., Bittleman, D., Cruz, D., Endre, Z., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.2 · Cited by 1,537
Self-citationDiscovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Kashani, K., Al-Khafaji, A., Ardiles, T., Artigas, A., Bagshaw, S. M., Bell, M., Bihorac, A., Birkhahn, R., Cely, C. M., Chawla, L. S., et al. (2013) · Critical Care · doi:10.1186/cc12503 · Cited by 1,362
Self-citationInitiation strategies for renal-replacement therapy in the intensive care unit.
Gaudry, S., Hajage, D., Schortgen, F., Martin-Lefevre, L., Pons, B., Boulet, E., Boyer, A., Chevrel, G., Lerolle, N., Carpentier, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603017 · Cited by 1,243
Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD
Ferenbach, D. A., & Bonventre, J. V. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.3 · Cited by 876
Recovery after Acute Kidney Injury
Kellum, J. A., Sileanu, F. E., Bihorac, A., Hoste, E. A. J., & Chawla, L. S. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0799oc · Cited by 520
Self-citationNiewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., Park, J., Nair, V., Schlafly, A., Saulnier, P.-J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0415-5 · Cited by 432
In situ immune complex formation and glomerular injury
Couser, W. G., & Salant, D. J. (1980) · Kidney International · doi:10.1038/ki.1980.1 · Cited by 379
Macrophages in Renal Injury and Repair
Huen, S. C., & Cantley, L. G. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034219 · Cited by 377
Assessment of the accuracy of diagnostic tests: the cross-sectional study
Knottnerus, J. A., & Muris, J. W. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00206-3 · Cited by 312
Koyner, J. L., Shaw, A. D., Chawla, L. S., Hoste, E. A. J., Bihorac, A., Kashani, K., Haase, M., Shi, J., & Kellum, J. A. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014060556 · Cited by 231
Self-citationClinical Trial Endpoints in Acute Kidney Injury
Billings IV, F. T., & Shaw, A. D. (2014) · Nephron Clinical Practice · doi:10.1159/000363725 · Cited by 190
Périnel, S., Vincent, F., Lautrette, A., Dellamonica, J., Mariat, C., Zéni, F., Cohen, Y., Tardy, B., Souweine, B., & Darmon, M. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001077 · Cited by 146
Macrophage Phenotype in Kidney Injury and Repair
Meng, X., Tang, P. M., Li, J., & Lan, H. Y. (2015) · Kidney Diseases · doi:10.1159/000431214 · Cited by 138
Detheux, M., Ständker, L., Vakili, J., Münch, J., Forssmann, U., Adermann, K., Pöhlmann, S., Vassart, G., Kirchhoff, F., Parmentier, M., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1501 · Cited by 132
The prognostic importance of duration of AKI: a systematic review and meta-analysis
Mehta, S., Chauhan, K., Patel, A., Patel, S., Pinotti, R., Nadkarni, G. N., Parikh, C. R., & Coca, S. G. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0876-7 · Cited by 124
Loor, J. D., Decruyenaere, J. M. A., Demeyere, K., Nuytinck, L., Hoste, E. A. J., & Meyer, E. (2016) · Critical Care · doi:10.1186/s13054-016-1192-x · Cited by 48
Self-citationAn initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium
Rump, L. J. M., Mattey, D. L., Kehoe, O., & Middleton, J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.05.023 · Cited by 44
Bagshaw, S. M., Lamontagne, F., Joannidis, M., & Wald, R. (2016) · Critical Care · doi:10.1186/s13054-016-1424-0 · Cited by 38
Self-citationCCL genes in multiple sclerosis and systemic lupus erythematosus
Vyshkina, T., Sylvester, A., Sadiq, S. A., Bonilla, E., Perl, A., & Kálmán, B. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.05.016 · Cited by 26
IDEAL timing of renal replacement therapy in critical care
Forni, L. G., & Joannidis, M. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0088-1 · Cited by 9
Self-citation
Cited by
Kellum, J. A., Romagnani, P., Ashuntantang, G., Ronco, C., Zarbock, A., & Anders, H.-J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00284-z · Cited by 1,741
Self-citationOstermann, M., Zarbock, A., Goldstein, S., Kashani, K., Macedo, E., Murugan, R., Bell, M., Forni, L., Guzzi, L., Joannidis, M., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.19209 · Cited by 677
Self-citationAcute kidney injury in the critically ill: an updated review on pathophysiology and management
Pickkers, P., Darmon, M., Hoste, E., Joannidis, M., Legrand, M., Ostermann, M., Prowle, J. R., Schneider, A., & Schetz, M. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06454-7 · Cited by 549
Self-citationCalzavacca, P., Licari, E., & Bellomo, R. (2010) · Surgical Intensive Care Medicine · doi:10.1007/978-0-387-77893-8_38 · Cited by 533
Ostermann, M., Lumlertgul, N., Jeong, R., See, E., Joannidis, M., & James, M. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02385-7 · Cited by 396
Self-citation
Metadata
- Authors
- the RUBY Investigators, Hoste, E., Bihorac, A., Al-Khafaji, A., Ortega, L. M., Ostermann, M., Haase, M., Zacharowski, K., Wunderink, R., Heung, M., Lissauer, M., Self, W. H., Koyner, J. L., Honore, P. M., Prowle, J. R., Joannidis, M., Forni, L. G., Kampf, J. P., McPherson, P., Kellum, J. A., & Chawla, L. S.
- Venue
- Intensive Care Medicine
- Published
- 2020-02-06
- Volume
- 46
- Issue
- 5
- Pages
- 943-953
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W3005099669
- Cited by
- 255
- References
- 24
- FWCI
- 17.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.